Global Aujeszky Disease Vaccines Market Growth 2026-2032
The global Aujeszky Disease Vaccines market size is predicted to grow from US$ 165 million in 2025 to US$ 253 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.
Aujeszky Disease Vaccines, also known as swine pseudorabies vaccines, are veterinary biological products used to prevent pseudorabies virus infection in pigs. The product scope mainly includes live attenuated vaccines, inactivated vaccines, gene-deleted marker vaccines and combination vaccines containing pseudorabies virus antigens, with freeze-dried live vaccines and oil-emulsion inactivated vaccines as the main product forms. The most common and highest-volume strain platforms are Bartha-K61, HB98 and C strain, while JS-2012, HN1201, TP strain and HB2000 are better regarded as variant-strain or company-specific differentiated routes. Upstream inputs mainly include production strains, cell substrates, culture media, adjuvants, stabilizers, freeze-drying protectants, inactivating agents, packaging materials and cold-chain packaging. Downstream customers mainly include large-scale swine farming groups, breeding farms, commercial pig farms, veterinary drug distributors and animal disease control bodies. On an ex-factory finished-vaccine basis, global capacity in 2025 is estimated at about 2.28 billion doses, actual sales volume at about 1.64 billion doses, and the average ex-factory ASP at around USD 0.10 per dose, with an industry gross margin of about 46%?61%. Conventional Chinese live vaccines are generally priced lower, while imported marker vaccines, variant-strain inactivated vaccines and combination products carry higher equivalent ASPs.
The market for Aujeszky disease vaccines is already a mature segment within swine vaccines, with stable baseline immunization demand but clear regional differences in market activity. In parts of Europe and North America, disease eradication and monitoring systems are relatively mature, so routine commercial vaccine demand is more stable and concentrated among a limited number of multinational animal health companies. China and selected intensive swine-producing regions in Asia remain the major demand centers, as large-scale farms continue to focus on sow herd stability, piglet survival, reproductive performance and herd purification. In China, mainstream strain platforms such as Bartha-K61, HB98 and C strain still account for a large share of routine vaccination, while variant-strain inactivated vaccines, gene-deleted marker vaccines and combination vaccines are mainly used for differentiated disease-control needs.
Looking ahead, market growth will not be driven mainly by wider basic adoption, but by product upgrading, herd purification, consolidation of large-scale farms and more precise immunization programs. As integrated swine producers raise their requirements for comprehensive disease prevention, vaccine suppliers will increasingly compete through combined capabilities in vaccines, diagnostics, immunization planning and technical services. Strain matching, antigen stability, duration of immunity, batch-to-batch consistency, DIVA compatibility and compatibility with other swine vaccination programs will become more important in product evaluation. Companies with strong strain reserves, stable manufacturing processes and service capabilities for large-scale farms are likely to gain stronger positions among high-end customers and purification-oriented farms.
The main growth drivers include the expansion of intensive pig farming, normalized disease prevention, the need to improve sow productivity and demand for regional herd purification. Once pseudorabies spreads within a farm, it can cause significant production losses in breeding sows, piglets and fattening pigs, so large-scale farms usually maintain relatively stable vaccination spending. In China, integrated producers are placing higher requirements on vaccine quality, field efficacy and technical support, encouraging manufacturers to accelerate upgrades in live vaccines, inactivated vaccines, marker vaccines and combination products. Animal disease-control policies, tighter regulation of veterinary biological products, higher standards for large-scale farming and improved farm biosecurity systems also provide a long-term foundation for high-quality vaccine suppliers.
Key restraints include hog-cycle volatility, product homogenization, lower demand in purified regions and the difficulty of proving meaningful product differentiation. When farm profitability declines, some small and medium-sized farms may reduce disease-prevention budgets, affecting routine vaccine purchases. At the same time, many suppliers compete in mainstream strain platforms, creating pressure from pricing and channels. For manufacturers, variant-strain vaccines, gene-deleted marker vaccines and combination products offer upgrade potential, but they require sustained investment in research, registration, field validation and production quality control, resulting in a relatively long commercialization cycle. The market is expected to become more concentrated around companies with broader product portfolios, stable manufacturing quality, access to large farming groups and comprehensive technical service capabilities, while smaller suppliers without clear differentiation may face increasing competitive pressure.
LP Information, Inc. (LPI) ' newest research report, the ?Aujeszky Disease Vaccines Industry Forecast? looks at past sales and reviews total world Aujeszky Disease Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Aujeszky Disease Vaccines sales for 2026 through 2032. With Aujeszky Disease Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aujeszky Disease Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Aujeszky Disease Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aujeszky Disease Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Aujeszky Disease Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aujeszky Disease Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aujeszky Disease Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Aujeszky Disease Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Aujeszky Disease Vaccines market?
What factors are driving Aujeszky Disease Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aujeszky Disease Vaccines market opportunities vary by end market size?
How does Aujeszky Disease Vaccines break out by Type, by Application?
Aujeszky Disease Vaccines, also known as swine pseudorabies vaccines, are veterinary biological products used to prevent pseudorabies virus infection in pigs. The product scope mainly includes live attenuated vaccines, inactivated vaccines, gene-deleted marker vaccines and combination vaccines containing pseudorabies virus antigens, with freeze-dried live vaccines and oil-emulsion inactivated vaccines as the main product forms. The most common and highest-volume strain platforms are Bartha-K61, HB98 and C strain, while JS-2012, HN1201, TP strain and HB2000 are better regarded as variant-strain or company-specific differentiated routes. Upstream inputs mainly include production strains, cell substrates, culture media, adjuvants, stabilizers, freeze-drying protectants, inactivating agents, packaging materials and cold-chain packaging. Downstream customers mainly include large-scale swine farming groups, breeding farms, commercial pig farms, veterinary drug distributors and animal disease control bodies. On an ex-factory finished-vaccine basis, global capacity in 2025 is estimated at about 2.28 billion doses, actual sales volume at about 1.64 billion doses, and the average ex-factory ASP at around USD 0.10 per dose, with an industry gross margin of about 46%?61%. Conventional Chinese live vaccines are generally priced lower, while imported marker vaccines, variant-strain inactivated vaccines and combination products carry higher equivalent ASPs.
The market for Aujeszky disease vaccines is already a mature segment within swine vaccines, with stable baseline immunization demand but clear regional differences in market activity. In parts of Europe and North America, disease eradication and monitoring systems are relatively mature, so routine commercial vaccine demand is more stable and concentrated among a limited number of multinational animal health companies. China and selected intensive swine-producing regions in Asia remain the major demand centers, as large-scale farms continue to focus on sow herd stability, piglet survival, reproductive performance and herd purification. In China, mainstream strain platforms such as Bartha-K61, HB98 and C strain still account for a large share of routine vaccination, while variant-strain inactivated vaccines, gene-deleted marker vaccines and combination vaccines are mainly used for differentiated disease-control needs.
Looking ahead, market growth will not be driven mainly by wider basic adoption, but by product upgrading, herd purification, consolidation of large-scale farms and more precise immunization programs. As integrated swine producers raise their requirements for comprehensive disease prevention, vaccine suppliers will increasingly compete through combined capabilities in vaccines, diagnostics, immunization planning and technical services. Strain matching, antigen stability, duration of immunity, batch-to-batch consistency, DIVA compatibility and compatibility with other swine vaccination programs will become more important in product evaluation. Companies with strong strain reserves, stable manufacturing processes and service capabilities for large-scale farms are likely to gain stronger positions among high-end customers and purification-oriented farms.
The main growth drivers include the expansion of intensive pig farming, normalized disease prevention, the need to improve sow productivity and demand for regional herd purification. Once pseudorabies spreads within a farm, it can cause significant production losses in breeding sows, piglets and fattening pigs, so large-scale farms usually maintain relatively stable vaccination spending. In China, integrated producers are placing higher requirements on vaccine quality, field efficacy and technical support, encouraging manufacturers to accelerate upgrades in live vaccines, inactivated vaccines, marker vaccines and combination products. Animal disease-control policies, tighter regulation of veterinary biological products, higher standards for large-scale farming and improved farm biosecurity systems also provide a long-term foundation for high-quality vaccine suppliers.
Key restraints include hog-cycle volatility, product homogenization, lower demand in purified regions and the difficulty of proving meaningful product differentiation. When farm profitability declines, some small and medium-sized farms may reduce disease-prevention budgets, affecting routine vaccine purchases. At the same time, many suppliers compete in mainstream strain platforms, creating pressure from pricing and channels. For manufacturers, variant-strain vaccines, gene-deleted marker vaccines and combination products offer upgrade potential, but they require sustained investment in research, registration, field validation and production quality control, resulting in a relatively long commercialization cycle. The market is expected to become more concentrated around companies with broader product portfolios, stable manufacturing quality, access to large farming groups and comprehensive technical service capabilities, while smaller suppliers without clear differentiation may face increasing competitive pressure.
LP Information, Inc. (LPI) ' newest research report, the ?Aujeszky Disease Vaccines Industry Forecast? looks at past sales and reviews total world Aujeszky Disease Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Aujeszky Disease Vaccines sales for 2026 through 2032. With Aujeszky Disease Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aujeszky Disease Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Aujeszky Disease Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aujeszky Disease Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Aujeszky Disease Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aujeszky Disease Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aujeszky Disease Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Aujeszky Disease Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Attenuated Vaccine
- Inactivated Vaccine
- Others
- Bartha-K61 Strain
- HB98 Strain
- C Strain
- Other
- Small Pack (Below 20 Doses per Vial)
- Medium Pack (20?50 Doses per Vial)
- Large Pack (Above 50 Doses per Vial)
- Large-scale Swine Farming Groups
- Breeding Farms
- Animal Disease Control Institutions
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MSD Animal Health
- Boehringer Ingelheim
- HIPRA
- Ceva Sant? Animale
- Wuhan Keqian Biology
- Pulike Biological Engineering
- China Animal Husbandry Industry
- Jinyu Bio-Technology
- Guangdong Winsun Bio-Pharmaceutical
- Huapai Biopharm
- Jilin Zhengye Biological Products
- Sinopharm Yangzhou VAC Biological Engineering
- Sinovet Animal Health
- Jofunhwa Group
- Harbin Weike Biotechnology
- Qilu Animal Health Products
- Harbin Pharmaceutical Group Bio-vaccine
- Qingdao Yebio Bioengineering
What is the 10-year outlook for the global Aujeszky Disease Vaccines market?
What factors are driving Aujeszky Disease Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aujeszky Disease Vaccines market opportunities vary by end market size?
How does Aujeszky Disease Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aujeszky Disease Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Aujeszky Disease Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Aujeszky Disease Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Aujeszky Disease Vaccines Segment by Type
2.2.1 Live Attenuated Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Others
2.2.4 Aujeszky Disease Vaccines Sales by Type
2.2.4.1 Global Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
2.2.4.2 Global Aujeszky Disease Vaccines Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Aujeszky Disease Vaccines Sale Price by Type (2021-2026)
2.3 Aujeszky Disease Vaccines Segment by Strain Platform
2.3.1 Bartha-K61 Strain
2.3.2 HB98 Strain
2.3.3 C Strain
2.3.4 Other
2.3.5 Aujeszky Disease Vaccines Sales by Strain Platform
2.3.5.1 Global Aujeszky Disease Vaccines Sales Market Share by Strain Platform (2021-2026)
2.3.5.2 Global Aujeszky Disease Vaccines Revenue and Market Share by Strain Platform (2021-2026)
2.3.5.3 Global Aujeszky Disease Vaccines Sale Price by Strain Platform (2021-2026)
2.4 Aujeszky Disease Vaccines Segment by Dose Pack Size
2.4.1 Small Pack (Below 20 Doses per Vial)
2.4.2 Medium Pack (20?50 Doses per Vial)
2.4.3 Large Pack (Above 50 Doses per Vial)
2.4.4 Aujeszky Disease Vaccines Sales by Dose Pack Size
2.4.4.1 Global Aujeszky Disease Vaccines Sales Market Share by Dose Pack Size (2021-2026)
2.4.4.2 Global Aujeszky Disease Vaccines Revenue and Market Share by Dose Pack Size (2021-2026)
2.4.4.3 Global Aujeszky Disease Vaccines Sale Price by Dose Pack Size (2021-2026)
2.5 Aujeszky Disease Vaccines Segment by Application
2.5.1 Large-scale Swine Farming Groups
2.5.2 Breeding Farms
2.5.3 Animal Disease Control Institutions
2.5.4 Others
2.5.5 Aujeszky Disease Vaccines Sales by Application
2.5.5.1 Global Aujeszky Disease Vaccines Sale Market Share by Application (2021-2026)
2.5.5.2 Global Aujeszky Disease Vaccines Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Aujeszky Disease Vaccines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Aujeszky Disease Vaccines Breakdown Data by Company
3.1.1 Global Aujeszky Disease Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Aujeszky Disease Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Aujeszky Disease Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Aujeszky Disease Vaccines Revenue by Company (2021-2026)
3.2.2 Global Aujeszky Disease Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Aujeszky Disease Vaccines Sale Price by Company
3.4 Key Manufacturers Aujeszky Disease Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aujeszky Disease Vaccines Product Location Distribution
3.4.2 Players Aujeszky Disease Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AUJESZKY DISEASE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Aujeszky Disease Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Aujeszky Disease Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Aujeszky Disease Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Aujeszky Disease Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Aujeszky Disease Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Aujeszky Disease Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Aujeszky Disease Vaccines Sales Growth
4.4 APAC Aujeszky Disease Vaccines Sales Growth
4.5 Europe Aujeszky Disease Vaccines Sales Growth
4.6 Middle East & Africa Aujeszky Disease Vaccines Sales Growth
5 AMERICAS
5.1 Americas Aujeszky Disease Vaccines Sales by Country
5.1.1 Americas Aujeszky Disease Vaccines Sales by Country (2021-2026)
5.1.2 Americas Aujeszky Disease Vaccines Revenue by Country (2021-2026)
5.2 Americas Aujeszky Disease Vaccines Sales by Type (2021-2026)
5.3 Americas Aujeszky Disease Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aujeszky Disease Vaccines Sales by Region
6.1.1 APAC Aujeszky Disease Vaccines Sales by Region (2021-2026)
6.1.2 APAC Aujeszky Disease Vaccines Revenue by Region (2021-2026)
6.2 APAC Aujeszky Disease Vaccines Sales by Type (2021-2026)
6.3 APAC Aujeszky Disease Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aujeszky Disease Vaccines by Country
7.1.1 Europe Aujeszky Disease Vaccines Sales by Country (2021-2026)
7.1.2 Europe Aujeszky Disease Vaccines Revenue by Country (2021-2026)
7.2 Europe Aujeszky Disease Vaccines Sales by Type (2021-2026)
7.3 Europe Aujeszky Disease Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aujeszky Disease Vaccines by Country
8.1.1 Middle East & Africa Aujeszky Disease Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Aujeszky Disease Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Aujeszky Disease Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Aujeszky Disease Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aujeszky Disease Vaccines
10.3 Manufacturing Process Analysis of Aujeszky Disease Vaccines
10.4 Industry Chain Structure of Aujeszky Disease Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aujeszky Disease Vaccines Distributors
11.3 Aujeszky Disease Vaccines Customer
12 WORLD FORECAST REVIEW FOR AUJESZKY DISEASE VACCINES BY GEOGRAPHIC REGION
12.1 Global Aujeszky Disease Vaccines Market Size Forecast by Region
12.1.1 Global Aujeszky Disease Vaccines Forecast by Region (2027-2032)
12.1.2 Global Aujeszky Disease Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Aujeszky Disease Vaccines Forecast by Type (2027-2032)
12.7 Global Aujeszky Disease Vaccines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MSD Animal Health
13.1.1 MSD Animal Health Company Information
13.1.2 MSD Animal Health Aujeszky Disease Vaccines Product Portfolios and Specifications
13.1.3 MSD Animal Health Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MSD Animal Health Main Business Overview
13.1.5 MSD Animal Health Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Aujeszky Disease Vaccines Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 HIPRA
13.3.1 HIPRA Company Information
13.3.2 HIPRA Aujeszky Disease Vaccines Product Portfolios and Specifications
13.3.3 HIPRA Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 HIPRA Main Business Overview
13.3.5 HIPRA Latest Developments
13.4 Ceva Sant? Animale
13.4.1 Ceva Sant? Animale Company Information
13.4.2 Ceva Sant? Animale Aujeszky Disease Vaccines Product Portfolios and Specifications
13.4.3 Ceva Sant? Animale Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Ceva Sant? Animale Main Business Overview
13.4.5 Ceva Sant? Animale Latest Developments
13.5 Wuhan Keqian Biology
13.5.1 Wuhan Keqian Biology Company Information
13.5.2 Wuhan Keqian Biology Aujeszky Disease Vaccines Product Portfolios and Specifications
13.5.3 Wuhan Keqian Biology Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Wuhan Keqian Biology Main Business Overview
13.5.5 Wuhan Keqian Biology Latest Developments
13.6 Pulike Biological Engineering
13.6.1 Pulike Biological Engineering Company Information
13.6.2 Pulike Biological Engineering Aujeszky Disease Vaccines Product Portfolios and Specifications
13.6.3 Pulike Biological Engineering Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pulike Biological Engineering Main Business Overview
13.6.5 Pulike Biological Engineering Latest Developments
13.7 China Animal Husbandry Industry
13.7.1 China Animal Husbandry Industry Company Information
13.7.2 China Animal Husbandry Industry Aujeszky Disease Vaccines Product Portfolios and Specifications
13.7.3 China Animal Husbandry Industry Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 China Animal Husbandry Industry Main Business Overview
13.7.5 China Animal Husbandry Industry Latest Developments
13.8 Jinyu Bio-Technology
13.8.1 Jinyu Bio-Technology Company Information
13.8.2 Jinyu Bio-Technology Aujeszky Disease Vaccines Product Portfolios and Specifications
13.8.3 Jinyu Bio-Technology Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jinyu Bio-Technology Main Business Overview
13.8.5 Jinyu Bio-Technology Latest Developments
13.9 Guangdong Winsun Bio-Pharmaceutical
13.9.1 Guangdong Winsun Bio-Pharmaceutical Company Information
13.9.2 Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Product Portfolios and Specifications
13.9.3 Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangdong Winsun Bio-Pharmaceutical Main Business Overview
13.9.5 Guangdong Winsun Bio-Pharmaceutical Latest Developments
13.10 Huapai Biopharm
13.10.1 Huapai Biopharm Company Information
13.10.2 Huapai Biopharm Aujeszky Disease Vaccines Product Portfolios and Specifications
13.10.3 Huapai Biopharm Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Huapai Biopharm Main Business Overview
13.10.5 Huapai Biopharm Latest Developments
13.11 Jilin Zhengye Biological Products
13.11.1 Jilin Zhengye Biological Products Company Information
13.11.2 Jilin Zhengye Biological Products Aujeszky Disease Vaccines Product Portfolios and Specifications
13.11.3 Jilin Zhengye Biological Products Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jilin Zhengye Biological Products Main Business Overview
13.11.5 Jilin Zhengye Biological Products Latest Developments
13.12 Sinopharm Yangzhou VAC Biological Engineering
13.12.1 Sinopharm Yangzhou VAC Biological Engineering Company Information
13.12.2 Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Product Portfolios and Specifications
13.12.3 Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sinopharm Yangzhou VAC Biological Engineering Main Business Overview
13.12.5 Sinopharm Yangzhou VAC Biological Engineering Latest Developments
13.13 Sinovet Animal Health
13.13.1 Sinovet Animal Health Company Information
13.13.2 Sinovet Animal Health Aujeszky Disease Vaccines Product Portfolios and Specifications
13.13.3 Sinovet Animal Health Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Sinovet Animal Health Main Business Overview
13.13.5 Sinovet Animal Health Latest Developments
13.14 Jofunhwa Group
13.14.1 Jofunhwa Group Company Information
13.14.2 Jofunhwa Group Aujeszky Disease Vaccines Product Portfolios and Specifications
13.14.3 Jofunhwa Group Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jofunhwa Group Main Business Overview
13.14.5 Jofunhwa Group Latest Developments
13.15 Harbin Weike Biotechnology
13.15.1 Harbin Weike Biotechnology Company Information
13.15.2 Harbin Weike Biotechnology Aujeszky Disease Vaccines Product Portfolios and Specifications
13.15.3 Harbin Weike Biotechnology Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Harbin Weike Biotechnology Main Business Overview
13.15.5 Harbin Weike Biotechnology Latest Developments
13.16 Qilu Animal Health Products
13.16.1 Qilu Animal Health Products Company Information
13.16.2 Qilu Animal Health Products Aujeszky Disease Vaccines Product Portfolios and Specifications
13.16.3 Qilu Animal Health Products Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Qilu Animal Health Products Main Business Overview
13.16.5 Qilu Animal Health Products Latest Developments
13.17 Harbin Pharmaceutical Group Bio-vaccine
13.17.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
13.17.2 Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Product Portfolios and Specifications
13.17.3 Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Harbin Pharmaceutical Group Bio-vaccine Main Business Overview
13.17.5 Harbin Pharmaceutical Group Bio-vaccine Latest Developments
13.18 Qingdao Yebio Bioengineering
13.18.1 Qingdao Yebio Bioengineering Company Information
13.18.2 Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Product Portfolios and Specifications
13.18.3 Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Qingdao Yebio Bioengineering Main Business Overview
13.18.5 Qingdao Yebio Bioengineering Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aujeszky Disease Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Aujeszky Disease Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Aujeszky Disease Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Aujeszky Disease Vaccines Segment by Type
2.2.1 Live Attenuated Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Others
2.2.4 Aujeszky Disease Vaccines Sales by Type
2.2.4.1 Global Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
2.2.4.2 Global Aujeszky Disease Vaccines Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Aujeszky Disease Vaccines Sale Price by Type (2021-2026)
2.3 Aujeszky Disease Vaccines Segment by Strain Platform
2.3.1 Bartha-K61 Strain
2.3.2 HB98 Strain
2.3.3 C Strain
2.3.4 Other
2.3.5 Aujeszky Disease Vaccines Sales by Strain Platform
2.3.5.1 Global Aujeszky Disease Vaccines Sales Market Share by Strain Platform (2021-2026)
2.3.5.2 Global Aujeszky Disease Vaccines Revenue and Market Share by Strain Platform (2021-2026)
2.3.5.3 Global Aujeszky Disease Vaccines Sale Price by Strain Platform (2021-2026)
2.4 Aujeszky Disease Vaccines Segment by Dose Pack Size
2.4.1 Small Pack (Below 20 Doses per Vial)
2.4.2 Medium Pack (20?50 Doses per Vial)
2.4.3 Large Pack (Above 50 Doses per Vial)
2.4.4 Aujeszky Disease Vaccines Sales by Dose Pack Size
2.4.4.1 Global Aujeszky Disease Vaccines Sales Market Share by Dose Pack Size (2021-2026)
2.4.4.2 Global Aujeszky Disease Vaccines Revenue and Market Share by Dose Pack Size (2021-2026)
2.4.4.3 Global Aujeszky Disease Vaccines Sale Price by Dose Pack Size (2021-2026)
2.5 Aujeszky Disease Vaccines Segment by Application
2.5.1 Large-scale Swine Farming Groups
2.5.2 Breeding Farms
2.5.3 Animal Disease Control Institutions
2.5.4 Others
2.5.5 Aujeszky Disease Vaccines Sales by Application
2.5.5.1 Global Aujeszky Disease Vaccines Sale Market Share by Application (2021-2026)
2.5.5.2 Global Aujeszky Disease Vaccines Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Aujeszky Disease Vaccines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Aujeszky Disease Vaccines Breakdown Data by Company
3.1.1 Global Aujeszky Disease Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Aujeszky Disease Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Aujeszky Disease Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Aujeszky Disease Vaccines Revenue by Company (2021-2026)
3.2.2 Global Aujeszky Disease Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Aujeszky Disease Vaccines Sale Price by Company
3.4 Key Manufacturers Aujeszky Disease Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aujeszky Disease Vaccines Product Location Distribution
3.4.2 Players Aujeszky Disease Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AUJESZKY DISEASE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Aujeszky Disease Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Aujeszky Disease Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Aujeszky Disease Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Aujeszky Disease Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Aujeszky Disease Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Aujeszky Disease Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Aujeszky Disease Vaccines Sales Growth
4.4 APAC Aujeszky Disease Vaccines Sales Growth
4.5 Europe Aujeszky Disease Vaccines Sales Growth
4.6 Middle East & Africa Aujeszky Disease Vaccines Sales Growth
5 AMERICAS
5.1 Americas Aujeszky Disease Vaccines Sales by Country
5.1.1 Americas Aujeszky Disease Vaccines Sales by Country (2021-2026)
5.1.2 Americas Aujeszky Disease Vaccines Revenue by Country (2021-2026)
5.2 Americas Aujeszky Disease Vaccines Sales by Type (2021-2026)
5.3 Americas Aujeszky Disease Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aujeszky Disease Vaccines Sales by Region
6.1.1 APAC Aujeszky Disease Vaccines Sales by Region (2021-2026)
6.1.2 APAC Aujeszky Disease Vaccines Revenue by Region (2021-2026)
6.2 APAC Aujeszky Disease Vaccines Sales by Type (2021-2026)
6.3 APAC Aujeszky Disease Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aujeszky Disease Vaccines by Country
7.1.1 Europe Aujeszky Disease Vaccines Sales by Country (2021-2026)
7.1.2 Europe Aujeszky Disease Vaccines Revenue by Country (2021-2026)
7.2 Europe Aujeszky Disease Vaccines Sales by Type (2021-2026)
7.3 Europe Aujeszky Disease Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aujeszky Disease Vaccines by Country
8.1.1 Middle East & Africa Aujeszky Disease Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Aujeszky Disease Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Aujeszky Disease Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Aujeszky Disease Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aujeszky Disease Vaccines
10.3 Manufacturing Process Analysis of Aujeszky Disease Vaccines
10.4 Industry Chain Structure of Aujeszky Disease Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aujeszky Disease Vaccines Distributors
11.3 Aujeszky Disease Vaccines Customer
12 WORLD FORECAST REVIEW FOR AUJESZKY DISEASE VACCINES BY GEOGRAPHIC REGION
12.1 Global Aujeszky Disease Vaccines Market Size Forecast by Region
12.1.1 Global Aujeszky Disease Vaccines Forecast by Region (2027-2032)
12.1.2 Global Aujeszky Disease Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Aujeszky Disease Vaccines Forecast by Type (2027-2032)
12.7 Global Aujeszky Disease Vaccines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MSD Animal Health
13.1.1 MSD Animal Health Company Information
13.1.2 MSD Animal Health Aujeszky Disease Vaccines Product Portfolios and Specifications
13.1.3 MSD Animal Health Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MSD Animal Health Main Business Overview
13.1.5 MSD Animal Health Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Aujeszky Disease Vaccines Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 HIPRA
13.3.1 HIPRA Company Information
13.3.2 HIPRA Aujeszky Disease Vaccines Product Portfolios and Specifications
13.3.3 HIPRA Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 HIPRA Main Business Overview
13.3.5 HIPRA Latest Developments
13.4 Ceva Sant? Animale
13.4.1 Ceva Sant? Animale Company Information
13.4.2 Ceva Sant? Animale Aujeszky Disease Vaccines Product Portfolios and Specifications
13.4.3 Ceva Sant? Animale Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Ceva Sant? Animale Main Business Overview
13.4.5 Ceva Sant? Animale Latest Developments
13.5 Wuhan Keqian Biology
13.5.1 Wuhan Keqian Biology Company Information
13.5.2 Wuhan Keqian Biology Aujeszky Disease Vaccines Product Portfolios and Specifications
13.5.3 Wuhan Keqian Biology Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Wuhan Keqian Biology Main Business Overview
13.5.5 Wuhan Keqian Biology Latest Developments
13.6 Pulike Biological Engineering
13.6.1 Pulike Biological Engineering Company Information
13.6.2 Pulike Biological Engineering Aujeszky Disease Vaccines Product Portfolios and Specifications
13.6.3 Pulike Biological Engineering Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pulike Biological Engineering Main Business Overview
13.6.5 Pulike Biological Engineering Latest Developments
13.7 China Animal Husbandry Industry
13.7.1 China Animal Husbandry Industry Company Information
13.7.2 China Animal Husbandry Industry Aujeszky Disease Vaccines Product Portfolios and Specifications
13.7.3 China Animal Husbandry Industry Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 China Animal Husbandry Industry Main Business Overview
13.7.5 China Animal Husbandry Industry Latest Developments
13.8 Jinyu Bio-Technology
13.8.1 Jinyu Bio-Technology Company Information
13.8.2 Jinyu Bio-Technology Aujeszky Disease Vaccines Product Portfolios and Specifications
13.8.3 Jinyu Bio-Technology Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jinyu Bio-Technology Main Business Overview
13.8.5 Jinyu Bio-Technology Latest Developments
13.9 Guangdong Winsun Bio-Pharmaceutical
13.9.1 Guangdong Winsun Bio-Pharmaceutical Company Information
13.9.2 Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Product Portfolios and Specifications
13.9.3 Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangdong Winsun Bio-Pharmaceutical Main Business Overview
13.9.5 Guangdong Winsun Bio-Pharmaceutical Latest Developments
13.10 Huapai Biopharm
13.10.1 Huapai Biopharm Company Information
13.10.2 Huapai Biopharm Aujeszky Disease Vaccines Product Portfolios and Specifications
13.10.3 Huapai Biopharm Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Huapai Biopharm Main Business Overview
13.10.5 Huapai Biopharm Latest Developments
13.11 Jilin Zhengye Biological Products
13.11.1 Jilin Zhengye Biological Products Company Information
13.11.2 Jilin Zhengye Biological Products Aujeszky Disease Vaccines Product Portfolios and Specifications
13.11.3 Jilin Zhengye Biological Products Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jilin Zhengye Biological Products Main Business Overview
13.11.5 Jilin Zhengye Biological Products Latest Developments
13.12 Sinopharm Yangzhou VAC Biological Engineering
13.12.1 Sinopharm Yangzhou VAC Biological Engineering Company Information
13.12.2 Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Product Portfolios and Specifications
13.12.3 Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sinopharm Yangzhou VAC Biological Engineering Main Business Overview
13.12.5 Sinopharm Yangzhou VAC Biological Engineering Latest Developments
13.13 Sinovet Animal Health
13.13.1 Sinovet Animal Health Company Information
13.13.2 Sinovet Animal Health Aujeszky Disease Vaccines Product Portfolios and Specifications
13.13.3 Sinovet Animal Health Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Sinovet Animal Health Main Business Overview
13.13.5 Sinovet Animal Health Latest Developments
13.14 Jofunhwa Group
13.14.1 Jofunhwa Group Company Information
13.14.2 Jofunhwa Group Aujeszky Disease Vaccines Product Portfolios and Specifications
13.14.3 Jofunhwa Group Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jofunhwa Group Main Business Overview
13.14.5 Jofunhwa Group Latest Developments
13.15 Harbin Weike Biotechnology
13.15.1 Harbin Weike Biotechnology Company Information
13.15.2 Harbin Weike Biotechnology Aujeszky Disease Vaccines Product Portfolios and Specifications
13.15.3 Harbin Weike Biotechnology Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Harbin Weike Biotechnology Main Business Overview
13.15.5 Harbin Weike Biotechnology Latest Developments
13.16 Qilu Animal Health Products
13.16.1 Qilu Animal Health Products Company Information
13.16.2 Qilu Animal Health Products Aujeszky Disease Vaccines Product Portfolios and Specifications
13.16.3 Qilu Animal Health Products Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Qilu Animal Health Products Main Business Overview
13.16.5 Qilu Animal Health Products Latest Developments
13.17 Harbin Pharmaceutical Group Bio-vaccine
13.17.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
13.17.2 Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Product Portfolios and Specifications
13.17.3 Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Harbin Pharmaceutical Group Bio-vaccine Main Business Overview
13.17.5 Harbin Pharmaceutical Group Bio-vaccine Latest Developments
13.18 Qingdao Yebio Bioengineering
13.18.1 Qingdao Yebio Bioengineering Company Information
13.18.2 Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Product Portfolios and Specifications
13.18.3 Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Qingdao Yebio Bioengineering Main Business Overview
13.18.5 Qingdao Yebio Bioengineering Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Aujeszky Disease Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Aujeszky Disease Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Major Players of Others
Table 6. Global Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 7. Global Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Table 8. Global Aujeszky Disease Vaccines Revenue by Type (2021-2026) & ($ million)
Table 9. Global Aujeszky Disease Vaccines Revenue Market Share by Type (2021-2026)
Table 10. Global Aujeszky Disease Vaccines Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Bartha-K61 Strain
Table 12. Major Players of HB98 Strain
Table 13. Major Players of C Strain
Table 14. Major Players of Other
Table 15. Global Aujeszky Disease Vaccines Sales by Strain Platform (2021-2026) & (K Dose)
Table 16. Global Aujeszky Disease Vaccines Sales Market Share by Strain Platform (2021-2026)
Table 17. Global Aujeszky Disease Vaccines Revenue by Strain Platform (2021-2026) & ($ million)
Table 18. Global Aujeszky Disease Vaccines Revenue Market Share by Strain Platform (2021-2026)
Table 19. Global Aujeszky Disease Vaccines Sale Price by Strain Platform (2021-2026) & (US$/Dose)
Table 20. Major Players of Small Pack (Below 20 Doses per Vial)
Table 21. Major Players of Medium Pack (20?50 Doses per Vial)
Table 22. Major Players of Large Pack (Above 50 Doses per Vial)
Table 23. Global Aujeszky Disease Vaccines Sales by Dose Pack Size (2021-2026) & (K Dose)
Table 24. Global Aujeszky Disease Vaccines Sales Market Share by Dose Pack Size (2021-2026)
Table 25. Global Aujeszky Disease Vaccines Revenue by Dose Pack Size (2021-2026) & ($ million)
Table 26. Global Aujeszky Disease Vaccines Revenue Market Share by Dose Pack Size (2021-2026)
Table 27. Global Aujeszky Disease Vaccines Sale Price by Dose Pack Size (2021-2026) & (US$/Dose)
Table 28. Global Aujeszky Disease Vaccines Sale by Application (2021-2026) & (K Dose)
Table 29. Global Aujeszky Disease Vaccines Sale Market Share by Application (2021-2026)
Table 30. Global Aujeszky Disease Vaccines Revenue by Application (2021-2026) & ($ million)
Table 31. Global Aujeszky Disease Vaccines Revenue Market Share by Application (2021-2026)
Table 32. Global Aujeszky Disease Vaccines Sale Price by Application (2021-2026) & (US$/Dose)
Table 33. Global Aujeszky Disease Vaccines Sales by Company (2021-2026) & (K Dose)
Table 34. Global Aujeszky Disease Vaccines Sales Market Share by Company (2021-2026)
Table 35. Global Aujeszky Disease Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Aujeszky Disease Vaccines Revenue Market Share by Company (2021-2026)
Table 37. Global Aujeszky Disease Vaccines Sale Price by Company (2021-2026) & (US$/Dose)
Table 38. Key Manufacturers Aujeszky Disease Vaccines Producing Area Distribution and Sales Area
Table 39. Players Aujeszky Disease Vaccines Products Offered
Table 40. Aujeszky Disease Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Aujeszky Disease Vaccines Sales by Geographic Region (2021-2026) & (K Dose)
Table 44. Global Aujeszky Disease Vaccines Sales Market Share Geographic Region (2021-2026)
Table 45. Global Aujeszky Disease Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Aujeszky Disease Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Aujeszky Disease Vaccines Sales by Country/Region (2021-2026) & (K Dose)
Table 48. Global Aujeszky Disease Vaccines Sales Market Share by Country/Region (2021-2026)
Table 49. Global Aujeszky Disease Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Aujeszky Disease Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Aujeszky Disease Vaccines Sales by Country (2021-2026) & (K Dose)
Table 52. Americas Aujeszky Disease Vaccines Sales Market Share by Country (2021-2026)
Table 53. Americas Aujeszky Disease Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 55. Americas Aujeszky Disease Vaccines Sales by Application (2021-2026) & (K Dose)
Table 56. APAC Aujeszky Disease Vaccines Sales by Region (2021-2026) & (K Dose)
Table 57. APAC Aujeszky Disease Vaccines Sales Market Share by Region (2021-2026)
Table 58. APAC Aujeszky Disease Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 60. APAC Aujeszky Disease Vaccines Sales by Application (2021-2026) & (K Dose)
Table 61. Europe Aujeszky Disease Vaccines Sales by Country (2021-2026) & (K Dose)
Table 62. Europe Aujeszky Disease Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 64. Europe Aujeszky Disease Vaccines Sales by Application (2021-2026) & (K Dose)
Table 65. Middle East & Africa Aujeszky Disease Vaccines Sales by Country (2021-2026) & (K Dose)
Table 66. Middle East & Africa Aujeszky Disease Vaccines Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 68. Middle East & Africa Aujeszky Disease Vaccines Sales by Application (2021-2026) & (K Dose)
Table 69. Key Market Drivers & Growth Opportunities of Aujeszky Disease Vaccines
Table 70. Key Market Challenges & Risks of Aujeszky Disease Vaccines
Table 71. Key Industry Trends of Aujeszky Disease Vaccines
Table 72. Aujeszky Disease Vaccines Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Aujeszky Disease Vaccines Distributors List
Table 75. Aujeszky Disease Vaccines Customer List
Table 76. Global Aujeszky Disease Vaccines Sales Forecast by Region (2027-2032) & (K Dose)
Table 77. Global Aujeszky Disease Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Aujeszky Disease Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 79. Americas Aujeszky Disease Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Aujeszky Disease Vaccines Sales Forecast by Region (2027-2032) & (K Dose)
Table 81. APAC Aujeszky Disease Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Aujeszky Disease Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 83. Europe Aujeszky Disease Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Aujeszky Disease Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 85. Middle East & Africa Aujeszky Disease Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Aujeszky Disease Vaccines Sales Forecast by Type (2027-2032) & (K Dose)
Table 87. Global Aujeszky Disease Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Aujeszky Disease Vaccines Sales Forecast by Application (2027-2032) & (K Dose)
Table 89. Global Aujeszky Disease Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. MSD Animal Health Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. MSD Animal Health Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 92. MSD Animal Health Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 93. MSD Animal Health Main Business
Table 94. MSD Animal Health Latest Developments
Table 95. Boehringer Ingelheim Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Boehringer Ingelheim Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 97. Boehringer Ingelheim Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 98. Boehringer Ingelheim Main Business
Table 99. Boehringer Ingelheim Latest Developments
Table 100. HIPRA Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. HIPRA Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 102. HIPRA Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 103. HIPRA Main Business
Table 104. HIPRA Latest Developments
Table 105. Ceva Sant? Animale Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Ceva Sant? Animale Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 107. Ceva Sant? Animale Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 108. Ceva Sant? Animale Main Business
Table 109. Ceva Sant? Animale Latest Developments
Table 110. Wuhan Keqian Biology Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. Wuhan Keqian Biology Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 112. Wuhan Keqian Biology Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 113. Wuhan Keqian Biology Main Business
Table 114. Wuhan Keqian Biology Latest Developments
Table 115. Pulike Biological Engineering Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Pulike Biological Engineering Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 117. Pulike Biological Engineering Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 118. Pulike Biological Engineering Main Business
Table 119. Pulike Biological Engineering Latest Developments
Table 120. China Animal Husbandry Industry Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. China Animal Husbandry Industry Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 122. China Animal Husbandry Industry Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 123. China Animal Husbandry Industry Main Business
Table 124. China Animal Husbandry Industry Latest Developments
Table 125. Jinyu Bio-Technology Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Jinyu Bio-Technology Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 127. Jinyu Bio-Technology Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 128. Jinyu Bio-Technology Main Business
Table 129. Jinyu Bio-Technology Latest Developments
Table 130. Guangdong Winsun Bio-Pharmaceutical Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 132. Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 133. Guangdong Winsun Bio-Pharmaceutical Main Business
Table 134. Guangdong Winsun Bio-Pharmaceutical Latest Developments
Table 135. Huapai Biopharm Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Huapai Biopharm Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 137. Huapai Biopharm Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 138. Huapai Biopharm Main Business
Table 139. Huapai Biopharm Latest Developments
Table 140. Jilin Zhengye Biological Products Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Jilin Zhengye Biological Products Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 142. Jilin Zhengye Biological Products Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 143. Jilin Zhengye Biological Products Main Business
Table 144. Jilin Zhengye Biological Products Latest Developments
Table 145. Sinopharm Yangzhou VAC Biological Engineering Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 147. Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 148. Sinopharm Yangzhou VAC Biological Engineering Main Business
Table 149. Sinopharm Yangzhou VAC Biological Engineering Latest Developments
Table 150. Sinovet Animal Health Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 151. Sinovet Animal Health Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 152. Sinovet Animal Health Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 153. Sinovet Animal Health Main Business
Table 154. Sinovet Animal Health Latest Developments
Table 155. Jofunhwa Group Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 156. Jofunhwa Group Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 157. Jofunhwa Group Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 158. Jofunhwa Group Main Business
Table 159. Jofunhwa Group Latest Developments
Table 160. Harbin Weike Biotechnology Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 161. Harbin Weike Biotechnology Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 162. Harbin Weike Biotechnology Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 163. Harbin Weike Biotechnology Main Business
Table 164. Harbin Weike Biotechnology Latest Developments
Table 165. Qilu Animal Health Products Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 166. Qilu Animal Health Products Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 167. Qilu Animal Health Products Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 168. Qilu Animal Health Products Main Business
Table 169. Qilu Animal Health Products Latest Developments
Table 170. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 171. Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 172. Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 173. Harbin Pharmaceutical Group Bio-vaccine Main Business
Table 174. Harbin Pharmaceutical Group Bio-vaccine Latest Developments
Table 175. Qingdao Yebio Bioengineering Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 176. Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 177. Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 178. Qingdao Yebio Bioengineering Main Business
Table 179. Qingdao Yebio Bioengineering Latest Developments
Table 1. Aujeszky Disease Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Aujeszky Disease Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Major Players of Others
Table 6. Global Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 7. Global Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Table 8. Global Aujeszky Disease Vaccines Revenue by Type (2021-2026) & ($ million)
Table 9. Global Aujeszky Disease Vaccines Revenue Market Share by Type (2021-2026)
Table 10. Global Aujeszky Disease Vaccines Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Bartha-K61 Strain
Table 12. Major Players of HB98 Strain
Table 13. Major Players of C Strain
Table 14. Major Players of Other
Table 15. Global Aujeszky Disease Vaccines Sales by Strain Platform (2021-2026) & (K Dose)
Table 16. Global Aujeszky Disease Vaccines Sales Market Share by Strain Platform (2021-2026)
Table 17. Global Aujeszky Disease Vaccines Revenue by Strain Platform (2021-2026) & ($ million)
Table 18. Global Aujeszky Disease Vaccines Revenue Market Share by Strain Platform (2021-2026)
Table 19. Global Aujeszky Disease Vaccines Sale Price by Strain Platform (2021-2026) & (US$/Dose)
Table 20. Major Players of Small Pack (Below 20 Doses per Vial)
Table 21. Major Players of Medium Pack (20?50 Doses per Vial)
Table 22. Major Players of Large Pack (Above 50 Doses per Vial)
Table 23. Global Aujeszky Disease Vaccines Sales by Dose Pack Size (2021-2026) & (K Dose)
Table 24. Global Aujeszky Disease Vaccines Sales Market Share by Dose Pack Size (2021-2026)
Table 25. Global Aujeszky Disease Vaccines Revenue by Dose Pack Size (2021-2026) & ($ million)
Table 26. Global Aujeszky Disease Vaccines Revenue Market Share by Dose Pack Size (2021-2026)
Table 27. Global Aujeszky Disease Vaccines Sale Price by Dose Pack Size (2021-2026) & (US$/Dose)
Table 28. Global Aujeszky Disease Vaccines Sale by Application (2021-2026) & (K Dose)
Table 29. Global Aujeszky Disease Vaccines Sale Market Share by Application (2021-2026)
Table 30. Global Aujeszky Disease Vaccines Revenue by Application (2021-2026) & ($ million)
Table 31. Global Aujeszky Disease Vaccines Revenue Market Share by Application (2021-2026)
Table 32. Global Aujeszky Disease Vaccines Sale Price by Application (2021-2026) & (US$/Dose)
Table 33. Global Aujeszky Disease Vaccines Sales by Company (2021-2026) & (K Dose)
Table 34. Global Aujeszky Disease Vaccines Sales Market Share by Company (2021-2026)
Table 35. Global Aujeszky Disease Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Aujeszky Disease Vaccines Revenue Market Share by Company (2021-2026)
Table 37. Global Aujeszky Disease Vaccines Sale Price by Company (2021-2026) & (US$/Dose)
Table 38. Key Manufacturers Aujeszky Disease Vaccines Producing Area Distribution and Sales Area
Table 39. Players Aujeszky Disease Vaccines Products Offered
Table 40. Aujeszky Disease Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Aujeszky Disease Vaccines Sales by Geographic Region (2021-2026) & (K Dose)
Table 44. Global Aujeszky Disease Vaccines Sales Market Share Geographic Region (2021-2026)
Table 45. Global Aujeszky Disease Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Aujeszky Disease Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Aujeszky Disease Vaccines Sales by Country/Region (2021-2026) & (K Dose)
Table 48. Global Aujeszky Disease Vaccines Sales Market Share by Country/Region (2021-2026)
Table 49. Global Aujeszky Disease Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Aujeszky Disease Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Aujeszky Disease Vaccines Sales by Country (2021-2026) & (K Dose)
Table 52. Americas Aujeszky Disease Vaccines Sales Market Share by Country (2021-2026)
Table 53. Americas Aujeszky Disease Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 55. Americas Aujeszky Disease Vaccines Sales by Application (2021-2026) & (K Dose)
Table 56. APAC Aujeszky Disease Vaccines Sales by Region (2021-2026) & (K Dose)
Table 57. APAC Aujeszky Disease Vaccines Sales Market Share by Region (2021-2026)
Table 58. APAC Aujeszky Disease Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 60. APAC Aujeszky Disease Vaccines Sales by Application (2021-2026) & (K Dose)
Table 61. Europe Aujeszky Disease Vaccines Sales by Country (2021-2026) & (K Dose)
Table 62. Europe Aujeszky Disease Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 64. Europe Aujeszky Disease Vaccines Sales by Application (2021-2026) & (K Dose)
Table 65. Middle East & Africa Aujeszky Disease Vaccines Sales by Country (2021-2026) & (K Dose)
Table 66. Middle East & Africa Aujeszky Disease Vaccines Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Aujeszky Disease Vaccines Sales by Type (2021-2026) & (K Dose)
Table 68. Middle East & Africa Aujeszky Disease Vaccines Sales by Application (2021-2026) & (K Dose)
Table 69. Key Market Drivers & Growth Opportunities of Aujeszky Disease Vaccines
Table 70. Key Market Challenges & Risks of Aujeszky Disease Vaccines
Table 71. Key Industry Trends of Aujeszky Disease Vaccines
Table 72. Aujeszky Disease Vaccines Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Aujeszky Disease Vaccines Distributors List
Table 75. Aujeszky Disease Vaccines Customer List
Table 76. Global Aujeszky Disease Vaccines Sales Forecast by Region (2027-2032) & (K Dose)
Table 77. Global Aujeszky Disease Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Aujeszky Disease Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 79. Americas Aujeszky Disease Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Aujeszky Disease Vaccines Sales Forecast by Region (2027-2032) & (K Dose)
Table 81. APAC Aujeszky Disease Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Aujeszky Disease Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 83. Europe Aujeszky Disease Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Aujeszky Disease Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 85. Middle East & Africa Aujeszky Disease Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Aujeszky Disease Vaccines Sales Forecast by Type (2027-2032) & (K Dose)
Table 87. Global Aujeszky Disease Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Aujeszky Disease Vaccines Sales Forecast by Application (2027-2032) & (K Dose)
Table 89. Global Aujeszky Disease Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. MSD Animal Health Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. MSD Animal Health Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 92. MSD Animal Health Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 93. MSD Animal Health Main Business
Table 94. MSD Animal Health Latest Developments
Table 95. Boehringer Ingelheim Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Boehringer Ingelheim Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 97. Boehringer Ingelheim Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 98. Boehringer Ingelheim Main Business
Table 99. Boehringer Ingelheim Latest Developments
Table 100. HIPRA Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. HIPRA Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 102. HIPRA Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 103. HIPRA Main Business
Table 104. HIPRA Latest Developments
Table 105. Ceva Sant? Animale Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Ceva Sant? Animale Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 107. Ceva Sant? Animale Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 108. Ceva Sant? Animale Main Business
Table 109. Ceva Sant? Animale Latest Developments
Table 110. Wuhan Keqian Biology Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. Wuhan Keqian Biology Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 112. Wuhan Keqian Biology Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 113. Wuhan Keqian Biology Main Business
Table 114. Wuhan Keqian Biology Latest Developments
Table 115. Pulike Biological Engineering Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Pulike Biological Engineering Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 117. Pulike Biological Engineering Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 118. Pulike Biological Engineering Main Business
Table 119. Pulike Biological Engineering Latest Developments
Table 120. China Animal Husbandry Industry Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. China Animal Husbandry Industry Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 122. China Animal Husbandry Industry Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 123. China Animal Husbandry Industry Main Business
Table 124. China Animal Husbandry Industry Latest Developments
Table 125. Jinyu Bio-Technology Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Jinyu Bio-Technology Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 127. Jinyu Bio-Technology Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 128. Jinyu Bio-Technology Main Business
Table 129. Jinyu Bio-Technology Latest Developments
Table 130. Guangdong Winsun Bio-Pharmaceutical Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 132. Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 133. Guangdong Winsun Bio-Pharmaceutical Main Business
Table 134. Guangdong Winsun Bio-Pharmaceutical Latest Developments
Table 135. Huapai Biopharm Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Huapai Biopharm Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 137. Huapai Biopharm Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 138. Huapai Biopharm Main Business
Table 139. Huapai Biopharm Latest Developments
Table 140. Jilin Zhengye Biological Products Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Jilin Zhengye Biological Products Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 142. Jilin Zhengye Biological Products Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 143. Jilin Zhengye Biological Products Main Business
Table 144. Jilin Zhengye Biological Products Latest Developments
Table 145. Sinopharm Yangzhou VAC Biological Engineering Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 147. Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 148. Sinopharm Yangzhou VAC Biological Engineering Main Business
Table 149. Sinopharm Yangzhou VAC Biological Engineering Latest Developments
Table 150. Sinovet Animal Health Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 151. Sinovet Animal Health Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 152. Sinovet Animal Health Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 153. Sinovet Animal Health Main Business
Table 154. Sinovet Animal Health Latest Developments
Table 155. Jofunhwa Group Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 156. Jofunhwa Group Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 157. Jofunhwa Group Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 158. Jofunhwa Group Main Business
Table 159. Jofunhwa Group Latest Developments
Table 160. Harbin Weike Biotechnology Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 161. Harbin Weike Biotechnology Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 162. Harbin Weike Biotechnology Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 163. Harbin Weike Biotechnology Main Business
Table 164. Harbin Weike Biotechnology Latest Developments
Table 165. Qilu Animal Health Products Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 166. Qilu Animal Health Products Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 167. Qilu Animal Health Products Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 168. Qilu Animal Health Products Main Business
Table 169. Qilu Animal Health Products Latest Developments
Table 170. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 171. Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 172. Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 173. Harbin Pharmaceutical Group Bio-vaccine Main Business
Table 174. Harbin Pharmaceutical Group Bio-vaccine Latest Developments
Table 175. Qingdao Yebio Bioengineering Basic Information, Aujeszky Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 176. Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Product Portfolios and Specifications
Table 177. Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 178. Qingdao Yebio Bioengineering Main Business
Table 179. Qingdao Yebio Bioengineering Latest Developments
LIST OF FIGURES
Figure 1. Picture of Aujeszky Disease Vaccines
Figure 2. Aujeszky Disease Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aujeszky Disease Vaccines Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Aujeszky Disease Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Aujeszky Disease Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Aujeszky Disease Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Aujeszky Disease Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Attenuated Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Product Picture of Others
Figure 14. Global Aujeszky Disease Vaccines Sales Market Share by Type in 2026
Figure 15. Global Aujeszky Disease Vaccines Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Bartha-K61 Strain
Figure 17. Product Picture of HB98 Strain
Figure 18. Product Picture of C Strain
Figure 19. Product Picture of Other
Figure 20. Global Aujeszky Disease Vaccines Sales Market Share by Strain Platform in 2026
Figure 21. Global Aujeszky Disease Vaccines Revenue Market Share by Strain Platform (2021-2026)
Figure 22. Product Picture of Small Pack (Below 20 Doses per Vial)
Figure 23. Product Picture of Medium Pack (20?50 Doses per Vial)
Figure 24. Product Picture of Large Pack (Above 50 Doses per Vial)
Figure 25. Global Aujeszky Disease Vaccines Sales Market Share by Dose Pack Size in 2026
Figure 26. Global Aujeszky Disease Vaccines Revenue Market Share by Dose Pack Size (2021-2026)
Figure 27. Aujeszky Disease Vaccines Consumed in Large-scale Swine Farming Groups
Figure 28. Global Aujeszky Disease Vaccines Market: Large-scale Swine Farming Groups (2021-2026) & (K Dose)
Figure 29. Aujeszky Disease Vaccines Consumed in Breeding Farms
Figure 30. Global Aujeszky Disease Vaccines Market: Breeding Farms (2021-2026) & (K Dose)
Figure 31. Aujeszky Disease Vaccines Consumed in Animal Disease Control Institutions
Figure 32. Global Aujeszky Disease Vaccines Market: Animal Disease Control Institutions (2021-2026) & (K Dose)
Figure 33. Aujeszky Disease Vaccines Consumed in Others
Figure 34. Global Aujeszky Disease Vaccines Market: Others (2021-2026) & (K Dose)
Figure 35. Global Aujeszky Disease Vaccines Sale Market Share by Application (2025)
Figure 36. Global Aujeszky Disease Vaccines Revenue Market Share by Application in 2025
Figure 37. Aujeszky Disease Vaccines Sales by Company in 2025 (K Dose)
Figure 38. Global Aujeszky Disease Vaccines Sales Market Share by Company in 2025
Figure 39. Aujeszky Disease Vaccines Revenue by Company in 2025 ($ millions)
Figure 40. Global Aujeszky Disease Vaccines Revenue Market Share by Company in 2025
Figure 41. Global Aujeszky Disease Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Aujeszky Disease Vaccines Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Aujeszky Disease Vaccines Sales 2021-2026 (K Dose)
Figure 44. Americas Aujeszky Disease Vaccines Revenue 2021-2026 ($ millions)
Figure 45. APAC Aujeszky Disease Vaccines Sales 2021-2026 (K Dose)
Figure 46. APAC Aujeszky Disease Vaccines Revenue 2021-2026 ($ millions)
Figure 47. Europe Aujeszky Disease Vaccines Sales 2021-2026 (K Dose)
Figure 48. Europe Aujeszky Disease Vaccines Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Aujeszky Disease Vaccines Sales 2021-2026 (K Dose)
Figure 50. Middle East & Africa Aujeszky Disease Vaccines Revenue 2021-2026 ($ millions)
Figure 51. Americas Aujeszky Disease Vaccines Sales Market Share by Country in 2025
Figure 52. Americas Aujeszky Disease Vaccines Revenue Market Share by Country (2021-2026)
Figure 53. Americas Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Figure 54. Americas Aujeszky Disease Vaccines Sales Market Share by Application (2021-2026)
Figure 55. United States Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Aujeszky Disease Vaccines Sales Market Share by Region in 2025
Figure 60. APAC Aujeszky Disease Vaccines Revenue Market Share by Region (2021-2026)
Figure 61. APAC Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Figure 62. APAC Aujeszky Disease Vaccines Sales Market Share by Application (2021-2026)
Figure 63. China Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 67. India Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Aujeszky Disease Vaccines Sales Market Share by Country in 2025
Figure 71. Europe Aujeszky Disease Vaccines Revenue Market Share by Country (2021-2026)
Figure 72. Europe Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Figure 73. Europe Aujeszky Disease Vaccines Sales Market Share by Application (2021-2026)
Figure 74. Germany Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 75. France Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Aujeszky Disease Vaccines Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Aujeszky Disease Vaccines Sales Market Share by Application (2021-2026)
Figure 82. Egypt Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Aujeszky Disease Vaccines in 2026
Figure 88. Manufacturing Process Analysis of Aujeszky Disease Vaccines
Figure 89. Industry Chain Structure of Aujeszky Disease Vaccines
Figure 90. Channels of Distribution
Figure 91. Global Aujeszky Disease Vaccines Sales Market Forecast by Region (2027-2032)
Figure 92. Global Aujeszky Disease Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Aujeszky Disease Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Aujeszky Disease Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Aujeszky Disease Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Aujeszky Disease Vaccines Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Aujeszky Disease Vaccines
Figure 2. Aujeszky Disease Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aujeszky Disease Vaccines Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Aujeszky Disease Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Aujeszky Disease Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Aujeszky Disease Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Aujeszky Disease Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Attenuated Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Product Picture of Others
Figure 14. Global Aujeszky Disease Vaccines Sales Market Share by Type in 2026
Figure 15. Global Aujeszky Disease Vaccines Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Bartha-K61 Strain
Figure 17. Product Picture of HB98 Strain
Figure 18. Product Picture of C Strain
Figure 19. Product Picture of Other
Figure 20. Global Aujeszky Disease Vaccines Sales Market Share by Strain Platform in 2026
Figure 21. Global Aujeszky Disease Vaccines Revenue Market Share by Strain Platform (2021-2026)
Figure 22. Product Picture of Small Pack (Below 20 Doses per Vial)
Figure 23. Product Picture of Medium Pack (20?50 Doses per Vial)
Figure 24. Product Picture of Large Pack (Above 50 Doses per Vial)
Figure 25. Global Aujeszky Disease Vaccines Sales Market Share by Dose Pack Size in 2026
Figure 26. Global Aujeszky Disease Vaccines Revenue Market Share by Dose Pack Size (2021-2026)
Figure 27. Aujeszky Disease Vaccines Consumed in Large-scale Swine Farming Groups
Figure 28. Global Aujeszky Disease Vaccines Market: Large-scale Swine Farming Groups (2021-2026) & (K Dose)
Figure 29. Aujeszky Disease Vaccines Consumed in Breeding Farms
Figure 30. Global Aujeszky Disease Vaccines Market: Breeding Farms (2021-2026) & (K Dose)
Figure 31. Aujeszky Disease Vaccines Consumed in Animal Disease Control Institutions
Figure 32. Global Aujeszky Disease Vaccines Market: Animal Disease Control Institutions (2021-2026) & (K Dose)
Figure 33. Aujeszky Disease Vaccines Consumed in Others
Figure 34. Global Aujeszky Disease Vaccines Market: Others (2021-2026) & (K Dose)
Figure 35. Global Aujeszky Disease Vaccines Sale Market Share by Application (2025)
Figure 36. Global Aujeszky Disease Vaccines Revenue Market Share by Application in 2025
Figure 37. Aujeszky Disease Vaccines Sales by Company in 2025 (K Dose)
Figure 38. Global Aujeszky Disease Vaccines Sales Market Share by Company in 2025
Figure 39. Aujeszky Disease Vaccines Revenue by Company in 2025 ($ millions)
Figure 40. Global Aujeszky Disease Vaccines Revenue Market Share by Company in 2025
Figure 41. Global Aujeszky Disease Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Aujeszky Disease Vaccines Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Aujeszky Disease Vaccines Sales 2021-2026 (K Dose)
Figure 44. Americas Aujeszky Disease Vaccines Revenue 2021-2026 ($ millions)
Figure 45. APAC Aujeszky Disease Vaccines Sales 2021-2026 (K Dose)
Figure 46. APAC Aujeszky Disease Vaccines Revenue 2021-2026 ($ millions)
Figure 47. Europe Aujeszky Disease Vaccines Sales 2021-2026 (K Dose)
Figure 48. Europe Aujeszky Disease Vaccines Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Aujeszky Disease Vaccines Sales 2021-2026 (K Dose)
Figure 50. Middle East & Africa Aujeszky Disease Vaccines Revenue 2021-2026 ($ millions)
Figure 51. Americas Aujeszky Disease Vaccines Sales Market Share by Country in 2025
Figure 52. Americas Aujeszky Disease Vaccines Revenue Market Share by Country (2021-2026)
Figure 53. Americas Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Figure 54. Americas Aujeszky Disease Vaccines Sales Market Share by Application (2021-2026)
Figure 55. United States Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Aujeszky Disease Vaccines Sales Market Share by Region in 2025
Figure 60. APAC Aujeszky Disease Vaccines Revenue Market Share by Region (2021-2026)
Figure 61. APAC Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Figure 62. APAC Aujeszky Disease Vaccines Sales Market Share by Application (2021-2026)
Figure 63. China Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 67. India Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Aujeszky Disease Vaccines Sales Market Share by Country in 2025
Figure 71. Europe Aujeszky Disease Vaccines Revenue Market Share by Country (2021-2026)
Figure 72. Europe Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Figure 73. Europe Aujeszky Disease Vaccines Sales Market Share by Application (2021-2026)
Figure 74. Germany Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 75. France Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Aujeszky Disease Vaccines Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Aujeszky Disease Vaccines Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Aujeszky Disease Vaccines Sales Market Share by Application (2021-2026)
Figure 82. Egypt Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Aujeszky Disease Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Aujeszky Disease Vaccines in 2026
Figure 88. Manufacturing Process Analysis of Aujeszky Disease Vaccines
Figure 89. Industry Chain Structure of Aujeszky Disease Vaccines
Figure 90. Channels of Distribution
Figure 91. Global Aujeszky Disease Vaccines Sales Market Forecast by Region (2027-2032)
Figure 92. Global Aujeszky Disease Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Aujeszky Disease Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Aujeszky Disease Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Aujeszky Disease Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Aujeszky Disease Vaccines Revenue Market Share Forecast by Application (2027-2032)
